Published in Infect Immun on August 01, 1991
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06
Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria. Microbiol Mol Biol Rev (2006) 4.88
The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun (1993) 4.00
Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun (1992) 2.64
The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun (1994) 2.44
Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun (1997) 2.08
The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun (1997) 1.80
The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses. J Clin Invest (2002) 1.63
Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun (1999) 1.52
Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J Clin Invest (1998) 1.35
Staphylococcus aureus fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intracellular levels of bacteria. Infect Immun (2001) 1.33
Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog (2010) 1.24
Interaction of staphylococci with bone. Int J Med Microbiol (2009) 1.23
Effect of biofilms on recalcitrance of staphylococcal joint infection to antibiotic treatment. J Infect Dis (2014) 1.20
The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One (2009) 1.19
Role of the staphylococcal accessory gene regulator (sar) in septic arthritis. Infect Immun (1996) 1.17
The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus. Infect Immun (2011) 1.16
Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS One (2008) 1.14
Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun (1994) 1.08
Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol (1999) 1.06
Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infect Immun (1995) 0.98
Strain-specific association of cytotoxic activity and virulence of clinical Staphylococcus aureus isolates. Infect Immun (2003) 0.95
Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis. Arthritis Res (2000) 0.94
Protective role of sialophorin (CD43)-expressing cells in experimental Staphylococcus aureus infection. Infect Immun (1994) 0.91
Staphylococcus aureus causing osteomyelitis binds to a nonapeptide sequence in bone sialoprotein. Biochem J (1997) 0.91
The value of animal models in predicting genetic susceptibility to complex diseases such as rheumatoid arthritis. Arthritis Res Ther (2009) 0.88
Role of intercellular adhesion molecule 1 in pathogenesis of staphylococcal arthritis and in host defense against staphylococcal bacteremia. Infect Immun (1996) 0.87
Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligand. Infect Immun (2003) 0.86
Are B lymphocytes of importance in severe Staphylococcus aureus infections? Infect Immun (2000) 0.86
Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines. Inflamm Res (2012) 0.86
Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin Exp Immunol (2002) 0.84
The role of Mcl-1 in S. aureus-induced cytoprotection of infected macrophages. Mediators Inflamm (2013) 0.83
Clonal distribution of bone sialoprotein-binding protein gene among Staphylococcus aureus isolates associated with bloodstream infections. Folia Microbiol (Praha) (2014) 0.83
Impacts of enterotoxin gene cluster-encoded superantigens on local and systemic experimental Staphylococcus aureus infections. Eur J Clin Microbiol Infect Dis (2015) 0.81
The surface protein Pls of methicillin-resistant Staphylococcus aureus is a virulence factor in septic arthritis. Infect Immun (2005) 0.81
Differential arthritogenicity of Staphylococcus aureus strains isolated from biological samples. BMC Infect Dis (2013) 0.81
Combined antibiotic and free radical trap treatment is effective at combating Staphylococcus-aureus-induced septic arthritis. Arthritis Res (2002) 0.80
Inactivation of the Ecs ABC transporter of Staphylococcus aureus attenuates virulence by altering composition and function of bacterial wall. PLoS One (2010) 0.80
Mannitol utilisation is required for protection of Staphylococcus aureus from human skin antimicrobial fatty acids. PLoS One (2013) 0.79
IL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice. PLoS One (2015) 0.79
Deficiency of the Complement Component 3 but Not Factor B Aggravates Staphylococcus aureus Septic Arthritis in Mice. Infect Immun (2016) 0.78
Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. PLoS One (2016) 0.77
Possible protective role of chloramphenicol in TSST-1 and coagulase-positive Staphylococcus aureus-induced septic arthritis with altered levels of inflammatory mediators. Inflammation (2011) 0.77
Granulocyte-macrophage colony-stimulating factor in Staphylococcus aureus-induced arthritis. Infect Immun (1998) 0.76
Staphylococcus aureus-dependent septic arthritis in murine knee joints: local immune response and beneficial effects of vaccination. Sci Rep (2016) 0.75
Humanized Mouse Models of Staphylococcus aureus Infection. Front Immunol (2017) 0.75
RAGE Deficiency Impairs Bacterial Clearance in Murine Staphylococcal Sepsis, but Has No Significant Impact on Staphylococcal Septic Arthritis. PLoS One (2016) 0.75
V beta 11+ T-lymphocyte expansion by toxic shock syndrome toxin-1 differs in mice bearing H-2q versus H-2b haplotypes. Immunology (1998) 0.75
A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Anal Biochem (1982) 6.53
Fibronectin binds to Staphylococcus aureus. Nature (1978) 4.39
Bacterial arthritis. N Engl J Med (1985) 3.61
Rapid methods for isolation of human plasma fibronectin. Thromb Res (1982) 3.35
Presence of laminin receptors in Staphylococcus aureus. Science (1985) 2.79
Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J (1985) 2.55
Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum (1989) 2.04
The primary structure of a cell-binding bone sialoprotein. J Biol Chem (1988) 1.93
Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum (1990) 1.75
Selective binding of bone matrix sialoprotein to Staphylococcus aureus in osteomyelitis. Lancet (1987) 1.34
Specific attachment of Staphylococcus aureus to immobilized fibronectin. Infect Immun (1986) 1.31
Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis. Infect Immun (1990) 1.25
Animal models of infectious arthritis. Clin Rheum Dis (1986) 1.16
Specific binding of collagen to Staphylococcus aureus. Coll Relat Res (1985) 1.16
High surface hydrophobicity of autoaggregating Staphylococcus aureus strains isolated from human infections studied with the salt aggregation test. Infect Immun (1985) 1.12
Knee joint infections with Staphylococcus aureus and Micrococcus species. J Bone Joint Surg Am (1975) 0.98
Experimental E. coli arthritis in the rabbit. A model of infectious and post-infectious inflammatory synovitis. J Rheumatol (1977) 0.97
SYNOVITIS IN RABBITS DURING BACTEREMIA AND VACCINATION. Bull Johns Hopkins Hosp (1965) 0.96
Infection of rabbit knee joints after intra-articular injection of Staphylococcus aureus. Comparison with joints injected with Staphylococcus albus. Am J Pathol (1970) 0.94
Antigen-induced experimental septic arthritis in rabbits after intraarticular injection of Staphylococcus aureus. J Infect Dis (1986) 0.93
Experimental study of acute suppurative bone and joint infection. II. Suppurative arthritis. Chin Med J (Engl) (1983) 0.89
Adjusting for multiple testing--when and how? J Clin Epidemiol (2001) 8.85
A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods (1983) 6.71
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06
The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun (1993) 4.00
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med (1996) 3.41
Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology (1998) 3.00
Events per person year--a dubious concept. BMJ (1995) 2.65
Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun (1992) 2.64
The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun (1994) 2.44
Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet (1996) 2.20
Fibronectin receptors from Staphylococcus aureus. J Biol Chem (1983) 2.19
Correlation between intestinal synthesis of specific immunoglobulin A and protection against experimental cholera in mice. Infect Immun (1978) 2.12
Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun (1997) 2.08
Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity. Infect Immun (1993) 2.05
Binding of fibronectin to Staphylococcus strains. Infect Immun (1983) 1.96
Binding of fibronectin to the surface of group A, C, and G streptococci isolated from human infections. Eur J Clin Microbiol (1982) 1.91
Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies. Acta Pathol Microbiol Scand C (1978) 1.86
A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family. Biochem J (2000) 1.82
The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun (1997) 1.80
Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum (1990) 1.75
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol (1999) 1.68
Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun (2000) 1.65
Hearing screening in newborns: systematic review of accuracy, effectiveness, and effects of interventions after screening. Arch Dis Child (2009) 1.64
Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.62
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med (1999) 1.61
Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke (1995) 1.58
Antisecretory factor suppresses intestinal inflammation and hypersecretion. Gut (1997) 1.57
Autocrine loops with positive feedback enable context-dependent cell signaling. Am J Physiol Cell Physiol (2002) 1.55
Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun (1999) 1.52
Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol (1997) 1.51
Establishment and characterization of chicken embryo fibroblast clone LSCC-H32. In Vitro (1982) 1.46
[Effect of colloidal plasma substitutes on liberation of tumor necrosis factor-alpha (TNF-alpha) in human whole blood in vitro]. Infusionsther Transfusionsmed (1995) 1.41
[Benefit assessment of PET in malignant lymphomas. The IQWiG point of view]. Nuklearmedizin (2010) 1.39
Induction of anti-secretory factor in human milk may prevent mastitis. Acta Paediatr (2004) 1.39
Comparison of the efficacy and safety of aspirin alone with coumadin plus aspirin after provisional coronary stenting: final and follow-up results of a randomized study. Am Heart J (1999) 1.39
Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis (2003) 1.38
Toxin A of Clostridium difficile: production, purification and effect in mouse intestine. Acta Pathol Microbiol Immunol Scand B (1983) 1.37
Genistein as an anti-inflammatory agent. Inflamm Res (2003) 1.35
Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J Clin Invest (1998) 1.35
Selective binding of bone matrix sialoprotein to Staphylococcus aureus in osteomyelitis. Lancet (1987) 1.34
Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A (1994) 1.33
Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine. Gastroenterology (1978) 1.32
Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci. Eur J Immunol (1994) 1.32
Specific attachment of Staphylococcus aureus to immobilized fibronectin. Infect Immun (1986) 1.31
The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism. Infect Immun (2001) 1.30
The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology (1998) 1.30
Fetal heart rate variability and complexity in the course of pregnancy. Early Hum Dev (1999) 1.30
Mice with the xid B cell defect are less susceptible to developing Staphylococcus aureus-induced arthritis. J Immunol (1995) 1.28
Addition of corticosteroids to antibiotic treatment ameliorates the course of experimental Staphylococcus aureus arthritis. Arthritis Rheum (1996) 1.27
Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J Immunol (1995) 1.26
Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol (1990) 1.26
Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus (2000) 1.26
A demineralization procedure for immunohistopathological use. EDTA treatment preserves lymphoid cell surface antigens. J Immunol Methods (1986) 1.25
Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances. J Immunol Methods (1984) 1.21
Local cholera immunity in mice: intestinal antitoxin-containing cells and their correlation with protective immunity. Infect Immun (1979) 1.20
Role of T lymphocytes in experimental Staphylococcus aureus arthritis. Scand J Immunol (1994) 1.19
Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study. Clin Exp Immunol (1984) 1.19
Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol (1992) 1.19
Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis (2006) 1.18
Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J Clin Lab Immunol (1983) 1.18
TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J Immunol (1998) 1.18
Role of the staphylococcal accessory gene regulator (sar) in septic arthritis. Infect Immun (1996) 1.17
Multiple test procedures other than Bonferroni's deserve wider use. BMJ (1999) 1.17
Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology (1987) 1.17
Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue. J Immunol (1989) 1.16
Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis (2001) 1.16
The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool. Scand J Immunol (2007) 1.16
Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine. Gut (1990) 1.15
Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology (1989) 1.15
Multicentre study of fetal cardiac time intervals using magnetocardiography. BJOG (2002) 1.14
Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol (1992) 1.14
Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells. Cancer Gene Ther (2010) 1.13
Impaired cutaneous delayed-type hypersensitivity in autoimmune MRL lpr/lpr mice. Int Arch Allergy Appl Immunol (1986) 1.13
Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation (1993) 1.12
Simultaneous induction of rheumatoid factor- and antigen-specific antibody-secreting cells during the secondary immune response in man. Clin Exp Immunol (1985) 1.12
Polyclonal B-cell activation by an arthritogenic Staphylococcus aureus strain: contribution of T-cells and monokines. Cell Immunol (1993) 1.11
Learning with computerized guidelines in general practice?: A randomized controlled trial. Fam Pract (2004) 1.11
Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology (1996) 1.11
Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways. Oncogene (2001) 1.10
Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia. Acta Neurol Scand (2001) 1.10
Interaction of cholera toxin and toxin derivatives with lymphocytes. II. Modulating effects of cholera toxin on in vivo humoral and cellular immune responses. Int Arch Allergy Appl Immunol (1976) 1.10
Influence of paced maternal breathing on fetal-maternal heart rate coordination. Proc Natl Acad Sci U S A (2009) 1.09
Toxic shock syndrome toxin 1 contributes to the arthritogenicity of Staphylococcus aureus. J Infect Dis (1994) 1.09
Role of macrophages in Staphylococcus aureus-induced arthritis and sepsis. Arthritis Rheum (2000) 1.09
Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun (1994) 1.08
Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J Infect Dis (1999) 1.08
Evaluation of gliadin antibodies for detection of coeliac disease. Scand J Gastroenterol (1983) 1.07
Generation of monoclonal rheumatoid factors after immunization with collagen II-anti-collagen II immune complexes. An anti-idiotypic antibody to anti-collagen II is also a rheumatoid factor. Scand J Immunol (1986) 1.07
Endovascular therapy of brain AVMs prior to radiosurgery. Neurol Res (1998) 1.06
The effect of graded immersion on heart volume, central venous pressure, pulmonary blood distribution, and heart rate in man. Pflugers Arch (1978) 1.06
[Comparison of different stool tests for the detection of cancer of the colon]. Dtsch Med Wochenschr (2005) 1.06
Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol (1999) 1.06